FDA Authorizes Second COVID-19 Booster for Adults Aged 50 and Older
Moderna
mRNA Therapeutics Developer
Pfizer
Pharmaceutical R&D Developer
FDA
U.S. Food and Drug Administration
Centers for Disease Control and Prevention
The Centers for Disease Control and Prevention (CDC) is an agency under the U.S. Department of Health and Human Services, with its headquarters located in Atlanta, Georgia. As a federal government administrative agency, the CDC provides reliable information to protect public health and safety. Through strong partnerships with national health departments and other organizations, it aims to enhance health-related decision-making and promote the well-being of citizens.
To prevent a potential new wave of COVID-19 infections caused by the Omicron subvariant BA.2, on March 29 local time, the U.S. Food and Drug Administration (FDA) authorized a second booster dose of the Moderna and Pfizer COVID-19 vaccines for people aged 50 and older.
The U.S. Centers for Disease Control and Prevention (CDC) stated that anyone aged 50 or above can receive a second booster shot of the COVID-19 vaccine four months after their first booster, regardless of which company’s vaccine they initially received. (Reported by CCTV reporter Xu Tao)